SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4mif'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C4D_C_DVAC6_0 (GRAMICIDIN A)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	3 / 3	ALA A 595 VAL A 453 TRP A 451	None	0.77A	1c4dC-4mifA: undetectable 1c4dD-4mifA: undetectable	1c4dC-4mifA: 2.22 1c4dD-4mifA: 2.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DSC_C_DVAC8_0 (ACTINOMYCIN D)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	3 / 3	THR A 598 THR A 600 PRO A 597	FDA A 801 (-3.4A) None FDA A 801 (-4.1A)	0.80A	1dscC-4mifA: undetectable	1dscC-4mifA: 1.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FBM_B_RTLB951_0 (PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN))	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 4	THR A 600 LEU A 599 LEU A 242 GLN A 440	None	1.26A	1fbmA-4mifA: undetectable	1fbmA-4mifA: 5.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NV8_A_SAMA300_0 (HEMK PROTEIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	PRO A 75 ILE A 24 GLY A 22 GLY A 153 ALA A 257	None FDA A 801 (-3.7A) FDA A 801 (-3.2A) None None	1.06A	1nv8A-4mifA: 2.9	1nv8A-4mifA: 20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OE2_A_CUA502_0 (DISSIMILATORY COPPER-CONTAINING NITRITE REDUCTASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	3 / 3	GLU A 254 HIS A 256 HIS A 245	None	0.59A	1oe2A-4mifA: undetectable	1oe2A-4mifA: 20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RA8_A_FOLA161_1 (DIHYDROFOLATE REDUCTASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	3 / 3	ASP A 412 LYS A 417 ARG A 420	None	1.05A	1ra8A-4mifA: undetectable	1ra8A-4mifA: 15.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SG9_B_SAMB302_0 (HEMK PROTEIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	PRO A 75 ILE A 24 GLY A 22 GLY A 153 ALA A 257	None FDA A 801 (-3.7A) FDA A 801 (-3.2A) None None	1.01A	1sg9B-4mifA: 2.8	1sg9B-4mifA: 19.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TT0_A_ACTA4901_0 (PYRANOSE OXIDASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 6	THR A 160 GLN A 454 PHE A 480 HIS A 553 ASN A 596	FDA A 801 (-3.4A) None None FDA A 801 ( 4.8A) FDA A 801 (-4.1A)	0.24A	1tt0A-4mifA: 48.1	1tt0A-4mifA: 40.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TT0_B_ACTB3901_0 (PYRANOSE OXIDASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 6	THR A 160 GLN A 454 PHE A 480 HIS A 553 ASN A 596	FDA A 801 (-3.4A) None None FDA A 801 ( 4.8A) FDA A 801 (-4.1A)	0.21A	1tt0B-4mifA: 48.1	1tt0B-4mifA: 40.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TT0_C_ACTC6901_0 (PYRANOSE OXIDASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 6	THR A 160 GLN A 454 PHE A 480 HIS A 553 ASN A 596	FDA A 801 (-3.4A) None None FDA A 801 ( 4.8A) FDA A 801 (-4.1A)	0.24A	1tt0C-4mifA: 48.8	1tt0C-4mifA: 40.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TT0_D_ACTD5901_0 (PYRANOSE OXIDASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 6	THR A 160 GLN A 454 PHE A 480 HIS A 553 ASN A 596	FDA A 801 (-3.4A) None None FDA A 801 ( 4.8A) FDA A 801 (-4.1A)	0.24A	1tt0D-4mifA: 48.8	1tt0D-4mifA: 40.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BJF_A_DXCA330_0 (CHOLOYLGLYCINE HYDROLASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	CYH A 560 PHE A 28 ALA A 608 ILE A 203 ILE A 204	None	1.26A	2bjfA-4mifA: undetectable	2bjfA-4mifA: 18.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q0I_A_BEZA990_0 (QUINOLONE SIGNAL RESPONSE PROTEIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 8	ASP A 458 GLU A 438 HIS A 456 LEU A 242	None	1.09A	2q0iA-4mifA: undetectable	2q0iA-4mifA: 18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QO4_A_CHDA130_0 (LIVER-BASIC FATTY ACID BINDING PROTEIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	LEU A 262 ALA A 29 THR A 279 PHE A 50 ARG A 272	None	1.25A	2qo4A-4mifA: undetectable	2qo4A-4mifA: 12.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QO4_A_CHDA130_0 (LIVER-BASIC FATTY ACID BINDING PROTEIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	LEU A 262 ALA A 29 VAL A 39 THR A 279 ARG A 272	None	1.41A	2qo4A-4mifA: undetectable	2qo4A-4mifA: 12.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QO6_A_CHDA130_0 (LIVER-BASIC FATTY ACID BINDING PROTEIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	LEU A 262 ALA A 29 THR A 279 PHE A 50 ARG A 272	None	1.26A	2qo6A-4mifA: undetectable	2qo6A-4mifA: 12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V41_E_BEZE1222_0 (PEROXIREDOXIN 6.)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 7	VAL A 148 SER A 101 ARG A 150 PRO A 506	None	1.08A	2v41E-4mifA: undetectable 2v41F-4mifA: undetectable	2v41E-4mifA: 16.40 2v41F-4mifA: 16.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V41_G_BEZG1222_0 (PEROXIREDOXIN 6.)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 8	VAL A 148 SER A 101 ARG A 150 PRO A 506	None	1.09A	2v41G-4mifA: undetectable 2v41H-4mifA: undetectable	2v41G-4mifA: 16.40 2v41H-4mifA: 16.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEK_B_DIFB1374_1 (ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 6	TYR A 477 PRO A 439 ILE A 432 LEU A 399	None	1.18A	2wekB-4mifA: undetectable	2wekB-4mifA: 19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FPJ_A_SAMA301_0 (PUTATIVE UNCHARACTERIZED PROTEIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	GLY A 20 VAL A 42 ILE A 44 ALA A 331 VAL A 340	FDA A 801 (-3.4A) None FDA A 801 (-3.7A) None None	0.62A	3fpjA-4mifA: 2.7	3fpjA-4mifA: 19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LD6_A_KKKA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	TYR A 604 PHE A 28 GLY A 25 ALA A 331 THR A 337	None	1.33A	3ld6A-4mifA: undetectable	3ld6A-4mifA: 21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LD6_B_KKKB602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	TYR A 604 PHE A 28 GLY A 25 ALA A 331 THR A 337	None	1.36A	3ld6B-4mifA: undetectable	3ld6B-4mifA: 21.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSK_B_ACTB901_0 (PYRANOSE 2-OXIDASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 6	GLN A 454 PHE A 480 HIS A 553 ASN A 596	None None FDA A 801 ( 4.8A) FDA A 801 (-4.1A)	0.26A	3lskB-4mifA: 48.0	3lskB-4mifA: 40.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSK_D_ACTD901_0 (PYRANOSE 2-OXIDASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 6	GLN A 454 PHE A 480 HIS A 553 ASN A 596	None None FDA A 801 ( 4.8A) FDA A 801 (-4.1A)	0.31A	3lskD-4mifA: 50.7	3lskD-4mifA: 40.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N5P_B_H4BB600_1 (NITRIC OXIDE SYNTHASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 6	PHE A 275 GLU A 43 VAL A 152 ARG A 272	None FDA A 801 (-2.7A) None None	1.43A	3n5pA-4mifA: undetectable 3n5pB-4mifA: undetectable	3n5pA-4mifA: 21.11 3n5pB-4mifA: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R9T_C_BEZC264_0 (ECHA1_1)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 5	ALA A 145 GLU A 385 GLU A 146 ALA A 551	None	1.21A	3r9tC-4mifA: undetectable	3r9tC-4mifA: 18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SI7_C_ACTC4_0 (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 4	GLY A 151 GLY A 45 THR A 279 LEU A 277	FDA A 801 (-4.5A) None None None	0.93A	3si7C-4mifA: undetectable 3si7D-4mifA: undetectable	3si7C-4mifA: 18.58 3si7D-4mifA: 18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SNF_A_ACTA110_0 (PROTEIN P-30)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 5	ILE A 589 THR A 600 THR A 598 PHE A 166	None None FDA A 801 (-3.4A) None	1.09A	3snfA-4mifA: undetectable	3snfA-4mifA: 10.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B17_A_SAMA1358_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE M)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	SER A 156 PRO A 23 GLY A 22 GLY A 153 ASP A 34	None FDA A 801 (-3.5A) FDA A 801 (-3.2A) None None	0.86A	4b17A-4mifA: 2.3	4b17A-4mifA: 18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B17_A_SAMA1358_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE M)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	SER A 156 PRO A 23 GLY A 22 GLY A 153 ASP A 259	None FDA A 801 (-3.5A) FDA A 801 (-3.2A) None None	1.10A	4b17A-4mifA: 2.3	4b17A-4mifA: 18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ENH_A_FVXA602_1 (CHOLESTEROL 24-HYDROXYLASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	LEU A 262 ILE A 261 ALA A 331 GLY A 584 ALA A 26	None	1.02A	4enhA-4mifA: undetectable	4enhA-4mifA: 22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PCL_A_SAMA301_0 (O-METHYLTRANSFERASE FAMILY PROTEIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	ALA A 336 LEU A 341 GLY A 584 ALA A 605 ALA A 331	FDA A 801 (-3.4A) None None None None	1.18A	4pclA-4mifA: 3.0	4pclA-4mifA: 16.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Q15_A_HFGA803_1 (PROLINE--TRNA LIGASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	3 / 3	GLU A 178 THR A 442 HIS A 452	None	0.85A	4q15A-4mifA: 2.8	4q15A-4mifA: 21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Q15_B_HFGB803_1 (PROLINE--TRNA LIGASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	3 / 3	GLU A 178 THR A 442 HIS A 452	None	0.87A	4q15B-4mifA: undetectable	4q15B-4mifA: 21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QB9_D_PARD500_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 8	PHE A 275 SER A 21 THR A 279 ASP A 306	None FDA A 801 ( 4.3A) None None	1.38A	4qb9D-4mifA: undetectable	4qb9D-4mifA: 21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 9	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.18A	4qvlH-4mifA: 0.0 4qvlI-4mifA: 0.0	4qvlH-4mifA: 16.99 4qvlI-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.02A	4qvlK-4mifA: undetectable 4qvlL-4mifA: undetectable	4qvlK-4mifA: 16.55 4qvlL-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.17A	4qvlV-4mifA: 0.0 4qvlW-4mifA: 0.7	4qvlV-4mifA: 16.99 4qvlW-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.01A	4qvlY-4mifA: undetectable 4qvlZ-4mifA: undetectable	4qvlY-4mifA: 16.55 4qvlZ-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 9	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.02A	4qvmK-4mifA: undetectable 4qvmL-4mifA: undetectable	4qvmK-4mifA: 16.55 4qvmL-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.02A	4qvmY-4mifA: undetectable 4qvmZ-4mifA: undetectable	4qvmY-4mifA: 16.55 4qvmZ-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	THR A 27 ALA A 29 GLY A 585 ALA A 331 THR A 337	None None FDA A 801 (-3.4A) None None	1.20A	4qvnV-4mifA: undetectable 4qvnb-4mifA: undetectable	4qvnV-4mifA: 16.99 4qvnb-4mifA: 14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	THR A 27 ALA A 29 GLY A 585 ALA A 331 THR A 337	None None FDA A 801 (-3.4A) None None	1.19A	4qvnH-4mifA: undetectable 4qvnN-4mifA: undetectable	4qvnH-4mifA: 16.99 4qvnN-4mifA: 14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.22A	4qvpH-4mifA: undetectable 4qvpI-4mifA: undetectable	4qvpH-4mifA: 16.99 4qvpI-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.01A	4qvpK-4mifA: undetectable 4qvpL-4mifA: undetectable	4qvpK-4mifA: 16.55 4qvpL-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.21A	4qvpV-4mifA: undetectable 4qvpW-4mifA: undetectable	4qvpV-4mifA: 16.99 4qvpW-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.01A	4qvpY-4mifA: undetectable 4qvpZ-4mifA: undetectable	4qvpY-4mifA: 16.55 4qvpZ-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 149 CYH A 103 ALA A 334 GLY A 333 ALA A 336	None None None FDA A 801 ( 3.7A) FDA A 801 (-3.4A)	1.12A	4qvvH-4mifA: undetectable	4qvvH-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 149 CYH A 103 ALA A 334 GLY A 333 ALA A 336	None None None FDA A 801 ( 3.7A) FDA A 801 (-3.4A)	1.11A	4qvvV-4mifA: undetectable	4qvvV-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.19A	4qvwH-4mifA: 0.0 4qvwI-4mifA: undetectable	4qvwH-4mifA: 16.99 4qvwI-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.19A	4qvwV-4mifA: 0.0 4qvwW-4mifA: 0.7	4qvwV-4mifA: 16.99 4qvwW-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 149 CYH A 103 ALA A 334 GLY A 333 ALA A 336	None None None FDA A 801 ( 3.7A) FDA A 801 (-3.4A)	1.13A	4qvyH-4mifA: undetectable	4qvyH-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.22A	4qvyV-4mifA: undetectable 4qvyW-4mifA: undetectable	4qvyV-4mifA: 16.99 4qvyW-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.19A	4qw0H-4mifA: undetectable 4qw0I-4mifA: undetectable	4qw0H-4mifA: 16.99 4qw0I-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.22A	4qw0V-4mifA: undetectable 4qw0W-4mifA: undetectable	4qw0V-4mifA: 16.99 4qw0W-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.00A	4qw1K-4mifA: undetectable 4qw1L-4mifA: undetectable	4qw1K-4mifA: 16.39 4qw1L-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.00A	4qw1Y-4mifA: undetectable 4qw1Z-4mifA: undetectable	4qw1Y-4mifA: 16.39 4qw1Z-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.23A	4qw3H-4mifA: 0.0 4qw3I-4mifA: 0.0	4qw3H-4mifA: 16.99 4qw3I-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.02A	4qw3K-4mifA: undetectable 4qw3L-4mifA: undetectable	4qw3K-4mifA: 17.06 4qw3L-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.22A	4qw3V-4mifA: 0.0 4qw3W-4mifA: 0.7	4qw3V-4mifA: 16.99 4qw3W-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.02A	4qw3Y-4mifA: undetectable 4qw3Z-4mifA: undetectable	4qw3Y-4mifA: 17.06 4qw3Z-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4S0V_A_SUVA2001_2 (HUMAN OREXIN RECEPTOR TYPE 2 FUSION PROTEIN TO P. ABYSII GLYCOGEN SYNTHASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 5	PRO A 239 HIS A 452 TYR A 477 VAL A 475	None	1.30A	4s0vA-4mifA: 2.6	4s0vA-4mifA: 20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TZU_B_Y70B505_1 (PROTEIN CEREBLON)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 7	HIS A 256 TRP A 255 PHE A 211 THR A 598	None None None FDA A 801 (-3.4A)	1.36A	4tzuB-4mifA: undetectable 4tzuC-4mifA: undetectable	4tzuB-4mifA: 10.47 4tzuC-4mifA: 10.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YDQ_B_HFGB802_1 (PROLINE--TRNA LIGASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	3 / 3	GLU A 178 THR A 442 HIS A 452	None	0.82A	4ydqB-4mifA: undetectable	4ydqB-4mifA: 21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YVG_A_SAMA301_0 (TRNA (GUANINE-N(1)-)-METH YLTRANSFERASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	PRO A 597 GLY A 587 GLU A 146 ILE A 602 GLY A 585	FDA A 801 (-4.1A) None None None FDA A 801 (-3.4A)	1.06A	4yvgA-4mifA: undetectable	4yvgA-4mifA: 16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.02A	5bxnK-4mifA: undetectable 5bxnL-4mifA: undetectable	5bxnK-4mifA: 16.55 5bxnL-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.01A	5bxnY-4mifA: undetectable 5bxnZ-4mifA: undetectable	5bxnY-4mifA: 16.55 5bxnZ-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.23A	5cz7H-4mifA: 0.0 5cz7I-4mifA: undetectable	5cz7H-4mifA: 16.99 5cz7I-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.24A	5cz7V-4mifA: undetectable 5cz7W-4mifA: undetectable	5cz7V-4mifA: 16.99 5cz7W-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	THR A 557 GLN A 505 ALA A 334 ALA A 336 ASP A 499	None None None FDA A 801 (-3.4A) None	1.19A	5d0xH-4mifA: undetectable 5d0xI-4mifA: undetectable	5d0xH-4mifA: 16.99 5d0xI-4mifA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 9	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.00A	5d0xK-4mifA: undetectable 5d0xL-4mifA: undetectable	5d0xK-4mifA: 16.55 5d0xL-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 149 CYH A 103 ALA A 334 GLY A 333 ALA A 336	None None None FDA A 801 ( 3.7A) FDA A 801 (-3.4A)	1.11A	5d0xV-4mifA: undetectable	5d0xV-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 9	THR A 27 ALA A 29 GLY A 585 GLY A 584 ALA A 331	None None FDA A 801 (-3.4A) None None	1.01A	5d0xY-4mifA: undetectable 5d0xZ-4mifA: undetectable	5d0xY-4mifA: 16.55 5d0xZ-4mifA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESJ_A_TPFA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 8	PHE A 266 ILE A 74 PHE A 275 THR A 279 MET A 41	None	1.33A	5esjA-4mifA: 0.9	5esjA-4mifA: 23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FCT_A_C2FA402_0 (THYMIDYLATE SYNTHASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	PHE A 17 ASN A 280 LEU A 308 LEU A 277 ALA A 47	None	1.27A	5fctA-4mifA: undetectable	5fctA-4mifA: 18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J6H_A_NCAA402_0 (H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, Q10 ALPHA CHAIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	3 / 3	PRO A 180 ARG A 177 GLU A 590	None	1.00A	5j6hA-4mifA: undetectable	5j6hA-4mifA: 19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KB5_A_ADNA401_1 (ADENOSINE KINASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	ASP A 48 LEU A 100 GLY A 151 ALA A 99 GLY A 76	None None FDA A 801 (-4.5A) None None	1.03A	5kb5A-4mifA: 3.2	5kb5A-4mifA: 20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KR2_C_ROCC101_1 (PROTEASE PR5-SQV)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 9	ALA A 257 ASP A 259 GLY A 22 ILE A 24 THR A 149	None None FDA A 801 (-3.2A) FDA A 801 (-3.7A) None	1.24A	5kr2C-4mifA: undetectable	5kr2C-4mifA: 13.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF3_H_BO2H306_1 (PROTEASOME SUBUNIT BETA TYPE-7 PROTEASOME SUBUNIT BETA TYPE-3)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 10	THR A 149 CYH A 103 ALA A 334 GLY A 333 ALA A 336	None None None FDA A 801 ( 3.7A) FDA A 801 (-3.4A)	1.07A	5lf3H-4mifA: undetectable 5lf3I-4mifA: undetectable	5lf3H-4mifA: 15.36 5lf3I-4mifA: 16.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_H_6V8H305_0 (PROTEASOME SUBUNIT BETA TYPE-3 PROTEASOME SUBUNIT BETA TYPE-7)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 149 CYH A 103 ALA A 334 GLY A 333 ALA A 336	None None None FDA A 801 ( 3.7A) FDA A 801 (-3.4A)	1.05A	5lf7H-4mifA: undetectable 5lf7I-4mifA: undetectable	5lf7H-4mifA: 15.36 5lf7I-4mifA: 16.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_N_6V8N305_0 (PROTEASOME SUBUNIT BETA TYPE-6 PROTEASOME SUBUNIT BETA TYPE-7)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	THR A 27 ALA A 29 GLY A 585 ALA A 331 THR A 337	None None FDA A 801 (-3.4A) None None	1.20A	5lf7H-4mifA: undetectable 5lf7N-4mifA: undetectable	5lf7H-4mifA: 15.36 5lf7N-4mifA: 15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_V_6V8V303_0 (PROTEASOME SUBUNIT BETA TYPE-3 PROTEASOME SUBUNIT BETA TYPE-7)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 11	THR A 149 CYH A 103 ALA A 334 GLY A 333 ALA A 336	None None None FDA A 801 ( 3.7A) FDA A 801 (-3.4A)	1.04A	5lf7V-4mifA: undetectable 5lf7W-4mifA: undetectable	5lf7V-4mifA: 15.36 5lf7W-4mifA: 16.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YBB_B_SAMB601_1 (TYPE I RESTRICTION-MODIFICA TION SYSTEM METHYLTRANSFERASE SUBUNIT)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 7	GLY A 549 GLY A 144 GLU A 385 ASN A 586	None None None FDA A 801 (-3.3A)	0.78A	5ybbB-4mifA: undetectable	5ybbB-4mifA: 22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YIZ_K_EF2K501_1 (PROTEIN CEREBLON)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 7	HIS A 256 TRP A 255 PHE A 211 THR A 598	None None None FDA A 801 (-3.4A)	1.36A	5yizk-4mifA: 0.0 5yizt-4mifA: undetectable	5yizk-4mifA: 9.01 5yizt-4mifA: 9.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YJ1_Y_6ELY501_0 (PROTEIN CEREBLON)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 7	THR A 598 HIS A 256 TRP A 255 PHE A 211	FDA A 801 (-3.4A) None None None	1.37A	5yj1G-4mifA: 0.0 5yj1Y-4mifA: undetectable	5yj1G-4mifA: 10.64 5yj1Y-4mifA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EF6_A_ACTA405_0 (AMINOGLYCOSIDE PHOSPHOTRANSFERASE)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 6	ARG A 498 PRO A 506 GLN A 339 ILE A 371	None	1.39A	6ef6A-4mifA: undetectable	6ef6A-4mifA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_B_BO2B201_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-2)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	THR A 27 ALA A 29 GLY A 585 ALA A 331 THR A 337	None None FDA A 801 (-3.4A) None None	1.18A	6hwdV-4mifA: undetectable 6hwdb-4mifA: undetectable	6hwdV-4mifA: 8.76 6hwdb-4mifA: 9.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_N_BO2N201_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-2)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	5 / 12	THR A 27 ALA A 29 GLY A 585 ALA A 331 THR A 337	None None FDA A 801 (-3.4A) None None	1.19A	6hwdH-4mifA: undetectable 6hwdN-4mifA: undetectable	6hwdH-4mifA: 8.76 6hwdN-4mifA: 9.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6J20_A_GBQA1201_1 (SUBSTANCE-P RECEPTOR,ENDOLYSIN)	4mif	PYRANOSE 2-OXIDASE (Phanerochaete chrysosporium)	4 / 7	ILE A 323 GLU A 305 HIS A 281 VAL A 42	None	1.00A	6j20A-4mifA: undetectable	6j20A-4mifA: 21.83

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C4D_C_DVAC6_0","GRAMICIDIN A","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",3,"ALA A 595;VAL A 453;TRP A 451","None","0.77A","1c4dC-4mifA:undetectable;1c4dD-4mifA:undetectable","1c4dC-4mifA:2.22;1c4dD-4mifA:2.22"],["1DSC_C_DVAC8_0","ACTINOMYCIN D","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",3,"THR A 598;THR A 600;PRO A 597","FDA A 801 (-3.4A);None;FDA A 801 (-4.1A)","0.80A","1dscC-4mifA:undetectable","1dscC-4mifA:1.54"],["1FBM_B_RTLB951_0","PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN)","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"THR A 600;LEU A 599;LEU A 242;GLN A 440","None","1.26A","1fbmA-4mifA:undetectable","1fbmA-4mifA:5.02"],["1NV8_A_SAMA300_0","HEMK PROTEIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"PRO A  75;ILE A  24;GLY A  22;GLY A 153;ALA A 257","None;FDA A 801 (-3.7A);FDA A 801 (-3.2A);None;None","1.06A","1nv8A-4mifA:2.9","1nv8A-4mifA:20.17"],["1OE2_A_CUA502_0","DISSIMILATORY COPPER-CONTAINING NITRITE REDUCTASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",3,"GLU A 254;HIS A 256;HIS A 245","None","0.59A","1oe2A-4mifA:undetectable","1oe2A-4mifA:20.39"],["1RA8_A_FOLA161_1","DIHYDROFOLATE REDUCTASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",3,"ASP A 412;LYS A 417;ARG A 420","None","1.05A","1ra8A-4mifA:undetectable","1ra8A-4mifA:15.32"],["1SG9_B_SAMB302_0","HEMK PROTEIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"PRO A  75;ILE A  24;GLY A  22;GLY A 153;ALA A 257","None;FDA A 801 (-3.7A);FDA A 801 (-3.2A);None;None","1.01A","1sg9B-4mifA:2.8","1sg9B-4mifA:19.23"],["1TT0_A_ACTA4901_0","PYRANOSE OXIDASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 160;GLN A 454;PHE A 480;HIS A 553;ASN A 596","FDA A 801 (-3.4A);None;None;FDA A 801 ( 4.8A);FDA A 801 (-4.1A)","0.24A","1tt0A-4mifA:48.1","1tt0A-4mifA:40.72"],["1TT0_B_ACTB3901_0","PYRANOSE OXIDASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 160;GLN A 454;PHE A 480;HIS A 553;ASN A 596","FDA A 801 (-3.4A);None;None;FDA A 801 ( 4.8A);FDA A 801 (-4.1A)","0.21A","1tt0B-4mifA:48.1","1tt0B-4mifA:40.72"],["1TT0_C_ACTC6901_0","PYRANOSE OXIDASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 160;GLN A 454;PHE A 480;HIS A 553;ASN A 596","FDA A 801 (-3.4A);None;None;FDA A 801 ( 4.8A);FDA A 801 (-4.1A)","0.24A","1tt0C-4mifA:48.8","1tt0C-4mifA:40.72"],["1TT0_D_ACTD5901_0","PYRANOSE OXIDASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 160;GLN A 454;PHE A 480;HIS A 553;ASN A 596","FDA A 801 (-3.4A);None;None;FDA A 801 ( 4.8A);FDA A 801 (-4.1A)","0.24A","1tt0D-4mifA:48.8","1tt0D-4mifA:40.72"],["2BJF_A_DXCA330_0","CHOLOYLGLYCINE HYDROLASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"CYH A 560;PHE A  28;ALA A 608;ILE A 203;ILE A 204","None","1.26A","2bjfA-4mifA:undetectable","2bjfA-4mifA:18.45"],["2Q0I_A_BEZA990_0","QUINOLONE SIGNAL RESPONSE PROTEIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"ASP A 458;GLU A 438;HIS A 456;LEU A 242","None","1.09A","2q0iA-4mifA:undetectable","2q0iA-4mifA:18.21"],["2QO4_A_CHDA130_0","LIVER-BASIC FATTY ACID BINDING PROTEIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"LEU A 262;ALA A  29;THR A 279;PHE A  50;ARG A 272","None","1.25A","2qo4A-4mifA:undetectable","2qo4A-4mifA:12.07"],["2QO4_A_CHDA130_0","LIVER-BASIC FATTY ACID BINDING PROTEIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"LEU A 262;ALA A  29;VAL A  39;THR A 279;ARG A 272","None","1.41A","2qo4A-4mifA:undetectable","2qo4A-4mifA:12.07"],["2QO6_A_CHDA130_0","LIVER-BASIC FATTY ACID BINDING PROTEIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"LEU A 262;ALA A  29;THR A 279;PHE A  50;ARG A 272","None","1.26A","2qo6A-4mifA:undetectable","2qo6A-4mifA:12.72"],["2V41_E_BEZE1222_0","PEROXIREDOXIN 6.","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"VAL A 148;SER A 101;ARG A 150;PRO A 506","None","1.08A","2v41E-4mifA:undetectable;2v41F-4mifA:undetectable","2v41E-4mifA:16.40;2v41F-4mifA:16.40"],["2V41_G_BEZG1222_0","PEROXIREDOXIN 6.","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"VAL A 148;SER A 101;ARG A 150;PRO A 506","None","1.09A","2v41G-4mifA:undetectable;2v41H-4mifA:undetectable","2v41G-4mifA:16.40;2v41H-4mifA:16.40"],["2WEK_B_DIFB1374_1","ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"TYR A 477;PRO A 439;ILE A 432;LEU A 399","None","1.18A","2wekB-4mifA:undetectable","2wekB-4mifA:19.61"],["3FPJ_A_SAMA301_0","PUTATIVE UNCHARACTERIZED PROTEIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"GLY A  20;VAL A  42;ILE A  44;ALA A 331;VAL A 340","FDA A 801 (-3.4A);None;FDA A 801 (-3.7A);None;None","0.62A","3fpjA-4mifA:2.7","3fpjA-4mifA:19.59"],["3LD6_A_KKKA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"TYR A 604;PHE A  28;GLY A  25;ALA A 331;THR A 337","None","1.33A","3ld6A-4mifA:undetectable","3ld6A-4mifA:21.46"],["3LD6_B_KKKB602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"TYR A 604;PHE A  28;GLY A  25;ALA A 331;THR A 337","None","1.36A","3ld6B-4mifA:undetectable","3ld6B-4mifA:21.46"],["3LSK_B_ACTB901_0","PYRANOSE 2-OXIDASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"GLN A 454;PHE A 480;HIS A 553;ASN A 596","None;None;FDA A 801 ( 4.8A);FDA A 801 (-4.1A)","0.26A","3lskB-4mifA:48.0","3lskB-4mifA:40.58"],["3LSK_D_ACTD901_0","PYRANOSE 2-OXIDASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"GLN A 454;PHE A 480;HIS A 553;ASN A 596","None;None;FDA A 801 ( 4.8A);FDA A 801 (-4.1A)","0.31A","3lskD-4mifA:50.7","3lskD-4mifA:40.58"],["3N5P_B_H4BB600_1","NITRIC OXIDE SYNTHASE;NITRIC OXIDE SYNTHASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"PHE A 275;GLU A  43;VAL A 152;ARG A 272","None;FDA A 801 (-2.7A);None;None","1.43A","3n5pA-4mifA:undetectable;3n5pB-4mifA:undetectable","3n5pA-4mifA:21.11;3n5pB-4mifA:21.11"],["3R9T_C_BEZC264_0","ECHA1_1","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"ALA A 145;GLU A 385;GLU A 146;ALA A 551","None","1.21A","3r9tC-4mifA:undetectable","3r9tC-4mifA:18.97"],["3SI7_C_ACTC4_0","CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"GLY A 151;GLY A  45;THR A 279;LEU A 277","FDA A 801 (-4.5A);None;None;None","0.93A","3si7C-4mifA:undetectable;3si7D-4mifA:undetectable","3si7C-4mifA:18.58;3si7D-4mifA:18.58"],["3SNF_A_ACTA110_0","PROTEIN P-30","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"ILE A 589;THR A 600;THR A 598;PHE A 166","None;None;FDA A 801 (-3.4A);None","1.09A","3snfA-4mifA:undetectable","3snfA-4mifA:10.30"],["4B17_A_SAMA1358_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE M","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"SER A 156;PRO A  23;GLY A  22;GLY A 153;ASP A  34","None;FDA A 801 (-3.5A);FDA A 801 (-3.2A);None;None","0.86A","4b17A-4mifA:2.3","4b17A-4mifA:18.85"],["4B17_A_SAMA1358_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE M","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"SER A 156;PRO A  23;GLY A  22;GLY A 153;ASP A 259","None;FDA A 801 (-3.5A);FDA A 801 (-3.2A);None;None","1.10A","4b17A-4mifA:2.3","4b17A-4mifA:18.85"],["4ENH_A_FVXA602_1","CHOLESTEROL 24-HYDROXYLASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"LEU A 262;ILE A 261;ALA A 331;GLY A 584;ALA A  26","None","1.02A","4enhA-4mifA:undetectable","4enhA-4mifA:22.29"],["4PCL_A_SAMA301_0","O-METHYLTRANSFERASE FAMILY PROTEIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"ALA A 336;LEU A 341;GLY A 584;ALA A 605;ALA A 331","FDA A 801 (-3.4A);None;None;None;None","1.18A","4pclA-4mifA:3.0","4pclA-4mifA:16.11"],["4Q15_A_HFGA803_1","PROLINE--TRNA LIGASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",3,"GLU A 178;THR A 442;HIS A 452","None","0.85A","4q15A-4mifA:2.8","4q15A-4mifA:21.27"],["4Q15_B_HFGB803_1","PROLINE--TRNA LIGASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",3,"GLU A 178;THR A 442;HIS A 452","None","0.87A","4q15B-4mifA:undetectable","4q15B-4mifA:21.27"],["4QB9_D_PARD500_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"PHE A 275;SER A  21;THR A 279;ASP A 306","None;FDA A 801 ( 4.3A);None;None","1.38A","4qb9D-4mifA:undetectable","4qb9D-4mifA:21.06"],["4QVL_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.18A","4qvlH-4mifA:0.0;4qvlI-4mifA:0.0","4qvlH-4mifA:16.99;4qvlI-4mifA:15.87"],["4QVL_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.02A","4qvlK-4mifA:undetectable;4qvlL-4mifA:undetectable","4qvlK-4mifA:16.55;4qvlL-4mifA:16.99"],["4QVL_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.17A","4qvlV-4mifA:0.0;4qvlW-4mifA:0.7","4qvlV-4mifA:16.99;4qvlW-4mifA:15.87"],["4QVL_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.01A","4qvlY-4mifA:undetectable;4qvlZ-4mifA:undetectable","4qvlY-4mifA:16.55;4qvlZ-4mifA:16.99"],["4QVM_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.02A","4qvmK-4mifA:undetectable;4qvmL-4mifA:undetectable","4qvmK-4mifA:16.55;4qvmL-4mifA:16.99"],["4QVM_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.02A","4qvmY-4mifA:undetectable;4qvmZ-4mifA:undetectable","4qvmY-4mifA:16.55;4qvmZ-4mifA:16.99"],["4QVN_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;ALA A 331;THR A 337","None;None;FDA A 801 (-3.4A);None;None","1.20A","4qvnV-4mifA:undetectable;4qvnb-4mifA:undetectable","4qvnV-4mifA:16.99;4qvnb-4mifA:14.08"],["4QVN_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;ALA A 331;THR A 337","None;None;FDA A 801 (-3.4A);None;None","1.19A","4qvnH-4mifA:undetectable;4qvnN-4mifA:undetectable","4qvnH-4mifA:16.99;4qvnN-4mifA:14.08"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.22A","4qvpH-4mifA:undetectable;4qvpI-4mifA:undetectable","4qvpH-4mifA:16.99;4qvpI-4mifA:15.87"],["4QVP_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.01A","4qvpK-4mifA:undetectable;4qvpL-4mifA:undetectable","4qvpK-4mifA:16.55;4qvpL-4mifA:16.99"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.21A","4qvpV-4mifA:undetectable;4qvpW-4mifA:undetectable","4qvpV-4mifA:16.99;4qvpW-4mifA:15.87"],["4QVP_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.01A","4qvpY-4mifA:undetectable;4qvpZ-4mifA:undetectable","4qvpY-4mifA:16.55;4qvpZ-4mifA:16.99"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 149;CYH A 103;ALA A 334;GLY A 333;ALA A 336","None;None;None;FDA A 801 ( 3.7A);FDA A 801 (-3.4A)","1.12A","4qvvH-4mifA:undetectable","4qvvH-4mifA:16.99"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 149;CYH A 103;ALA A 334;GLY A 333;ALA A 336","None;None;None;FDA A 801 ( 3.7A);FDA A 801 (-3.4A)","1.11A","4qvvV-4mifA:undetectable","4qvvV-4mifA:16.99"],["4QVW_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.19A","4qvwH-4mifA:0.0;4qvwI-4mifA:undetectable","4qvwH-4mifA:16.99;4qvwI-4mifA:15.87"],["4QVW_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.19A","4qvwV-4mifA:0.0;4qvwW-4mifA:0.7","4qvwV-4mifA:16.99;4qvwW-4mifA:15.87"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 149;CYH A 103;ALA A 334;GLY A 333;ALA A 336","None;None;None;FDA A 801 ( 3.7A);FDA A 801 (-3.4A)","1.13A","4qvyH-4mifA:undetectable","4qvyH-4mifA:16.99"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.22A","4qvyV-4mifA:undetectable;4qvyW-4mifA:undetectable","4qvyV-4mifA:16.99;4qvyW-4mifA:15.87"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.19A","4qw0H-4mifA:undetectable;4qw0I-4mifA:undetectable","4qw0H-4mifA:16.99;4qw0I-4mifA:15.87"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.22A","4qw0V-4mifA:undetectable;4qw0W-4mifA:undetectable","4qw0V-4mifA:16.99;4qw0W-4mifA:15.87"],["4QW1_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.00A","4qw1K-4mifA:undetectable;4qw1L-4mifA:undetectable","4qw1K-4mifA:16.39;4qw1L-4mifA:16.99"],["4QW1_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.00A","4qw1Y-4mifA:undetectable;4qw1Z-4mifA:undetectable","4qw1Y-4mifA:16.39;4qw1Z-4mifA:16.99"],["4QW3_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.23A","4qw3H-4mifA:0.0;4qw3I-4mifA:0.0","4qw3H-4mifA:16.99;4qw3I-4mifA:15.87"],["4QW3_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.02A","4qw3K-4mifA:undetectable;4qw3L-4mifA:undetectable","4qw3K-4mifA:17.06;4qw3L-4mifA:16.99"],["4QW3_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.22A","4qw3V-4mifA:0.0;4qw3W-4mifA:0.7","4qw3V-4mifA:16.99;4qw3W-4mifA:15.87"],["4QW3_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.02A","4qw3Y-4mifA:undetectable;4qw3Z-4mifA:undetectable","4qw3Y-4mifA:17.06;4qw3Z-4mifA:16.99"],["4S0V_A_SUVA2001_2","HUMAN OREXIN RECEPTOR TYPE 2 FUSION PROTEIN TO P. ABYSII GLYCOGEN SYNTHASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"PRO A 239;HIS A 452;TYR A 477;VAL A 475","None","1.30A","4s0vA-4mifA:2.6","4s0vA-4mifA:20.88"],["4TZU_B_Y70B505_1","PROTEIN CEREBLON;PROTEIN CEREBLON","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"HIS A 256;TRP A 255;PHE A 211;THR A 598","None;None;None;FDA A 801 (-3.4A)","1.36A","4tzuB-4mifA:undetectable;4tzuC-4mifA:undetectable","4tzuB-4mifA:10.47;4tzuC-4mifA:10.47"],["4YDQ_B_HFGB802_1","PROLINE--TRNA LIGASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",3,"GLU A 178;THR A 442;HIS A 452","None","0.82A","4ydqB-4mifA:undetectable","4ydqB-4mifA:21.25"],["4YVG_A_SAMA301_0","TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"PRO A 597;GLY A 587;GLU A 146;ILE A 602;GLY A 585","FDA A 801 (-4.1A);None;None;None;FDA A 801 (-3.4A)","1.06A","4yvgA-4mifA:undetectable","4yvgA-4mifA:16.31"],["5BXN_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.02A","5bxnK-4mifA:undetectable;5bxnL-4mifA:undetectable","5bxnK-4mifA:16.55;5bxnL-4mifA:16.99"],["5BXN_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.01A","5bxnY-4mifA:undetectable;5bxnZ-4mifA:undetectable","5bxnY-4mifA:16.55;5bxnZ-4mifA:16.99"],["5CZ7_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.23A","5cz7H-4mifA:0.0;5cz7I-4mifA:undetectable","5cz7H-4mifA:16.99;5cz7I-4mifA:15.87"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.24A","5cz7V-4mifA:undetectable;5cz7W-4mifA:undetectable","5cz7V-4mifA:16.99;5cz7W-4mifA:15.87"],["5D0X_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 557;GLN A 505;ALA A 334;ALA A 336;ASP A 499","None;None;None;FDA A 801 (-3.4A);None","1.19A","5d0xH-4mifA:undetectable;5d0xI-4mifA:undetectable","5d0xH-4mifA:16.99;5d0xI-4mifA:15.87"],["5D0X_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.00A","5d0xK-4mifA:undetectable;5d0xL-4mifA:undetectable","5d0xK-4mifA:16.55;5d0xL-4mifA:16.99"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 149;CYH A 103;ALA A 334;GLY A 333;ALA A 336","None;None;None;FDA A 801 ( 3.7A);FDA A 801 (-3.4A)","1.11A","5d0xV-4mifA:undetectable","5d0xV-4mifA:16.99"],["5D0X_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;GLY A 584;ALA A 331","None;None;FDA A 801 (-3.4A);None;None","1.01A","5d0xY-4mifA:undetectable;5d0xZ-4mifA:undetectable","5d0xY-4mifA:16.55;5d0xZ-4mifA:16.99"],["5ESJ_A_TPFA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"PHE A 266;ILE A  74;PHE A 275;THR A 279;MET A  41","None","1.33A","5esjA-4mifA:0.9","5esjA-4mifA:23.02"],["5FCT_A_C2FA402_0","THYMIDYLATE SYNTHASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"PHE A  17;ASN A 280;LEU A 308;LEU A 277;ALA A  47","None","1.27A","5fctA-4mifA:undetectable","5fctA-4mifA:18.75"],["5J6H_A_NCAA402_0","H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, Q10 ALPHA CHAIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",3,"PRO A 180;ARG A 177;GLU A 590","None","1.00A","5j6hA-4mifA:undetectable","5j6hA-4mifA:19.74"],["5KB5_A_ADNA401_1","ADENOSINE KINASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"ASP A  48;LEU A 100;GLY A 151;ALA A  99;GLY A  76","None;None;FDA A 801 (-4.5A);None;None","1.03A","5kb5A-4mifA:3.2","5kb5A-4mifA:20.38"],["5KR2_C_ROCC101_1","PROTEASE PR5-SQV","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"ALA A 257;ASP A 259;GLY A  22;ILE A  24;THR A 149","None;None;FDA A 801 (-3.2A);FDA A 801 (-3.7A);None","1.24A","5kr2C-4mifA:undetectable","5kr2C-4mifA:13.05"],["5LF3_H_BO2H306_1","PROTEASOME SUBUNIT BETA TYPE-7;PROTEASOME SUBUNIT BETA TYPE-3","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 149;CYH A 103;ALA A 334;GLY A 333;ALA A 336","None;None;None;FDA A 801 ( 3.7A);FDA A 801 (-3.4A)","1.07A","5lf3H-4mifA:undetectable;5lf3I-4mifA:undetectable","5lf3H-4mifA:15.36;5lf3I-4mifA:16.40"],["5LF7_H_6V8H305_0","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 149;CYH A 103;ALA A 334;GLY A 333;ALA A 336","None;None;None;FDA A 801 ( 3.7A);FDA A 801 (-3.4A)","1.05A","5lf7H-4mifA:undetectable;5lf7I-4mifA:undetectable","5lf7H-4mifA:15.36;5lf7I-4mifA:16.40"],["5LF7_N_6V8N305_0","PROTEASOME SUBUNIT BETA TYPE-6;PROTEASOME SUBUNIT BETA TYPE-7","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;ALA A 331;THR A 337","None;None;FDA A 801 (-3.4A);None;None","1.20A","5lf7H-4mifA:undetectable;5lf7N-4mifA:undetectable","5lf7H-4mifA:15.36;5lf7N-4mifA:15.73"],["5LF7_V_6V8V303_0","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A 149;CYH A 103;ALA A 334;GLY A 333;ALA A 336","None;None;None;FDA A 801 ( 3.7A);FDA A 801 (-3.4A)","1.04A","5lf7V-4mifA:undetectable;5lf7W-4mifA:undetectable","5lf7V-4mifA:15.36;5lf7W-4mifA:16.40"],["5YBB_B_SAMB601_1","TYPE I RESTRICTION-MODIFICATION SYSTEM METHYLTRANSFERASE SUBUNIT","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"GLY A 549;GLY A 144;GLU A 385;ASN A 586","None;None;None;FDA A 801 (-3.3A)","0.78A","5ybbB-4mifA:undetectable","5ybbB-4mifA:22.63"],["5YIZ_K_EF2K501_1","PROTEIN CEREBLON;PROTEIN CEREBLON","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"HIS A 256;TRP A 255;PHE A 211;THR A 598","None;None;None;FDA A 801 (-3.4A)","1.36A","5yizk-4mifA:0.0;5yizt-4mifA:undetectable","5yizk-4mifA:9.01;5yizt-4mifA:9.01"],["5YJ1_Y_6ELY501_0","PROTEIN CEREBLON","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"THR A 598;HIS A 256;TRP A 255;PHE A 211","FDA A 801 (-3.4A);None;None;None","1.37A","5yj1G-4mifA:0.0;5yj1Y-4mifA:undetectable","5yj1G-4mifA:10.64;5yj1Y-4mifA:10.64"],["6EF6_A_ACTA405_0","AMINOGLYCOSIDE PHOSPHOTRANSFERASE","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"ARG A 498;PRO A 506;GLN A 339;ILE A 371","None","1.39A","6ef6A-4mifA:undetectable","6ef6A-4mifA:20.00"],["6HWD_B_BO2B201_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-2","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;ALA A 331;THR A 337","None;None;FDA A 801 (-3.4A);None;None","1.18A","6hwdV-4mifA:undetectable;6hwdb-4mifA:undetectable","6hwdV-4mifA:8.76;6hwdb-4mifA:9.09"],["6HWD_N_BO2N201_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-2","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",5,"THR A  27;ALA A  29;GLY A 585;ALA A 331;THR A 337","None;None;FDA A 801 (-3.4A);None;None","1.19A","6hwdH-4mifA:undetectable;6hwdN-4mifA:undetectable","6hwdH-4mifA:8.76;6hwdN-4mifA:9.09"],["6J20_A_GBQA1201_1","SUBSTANCE-P RECEPTOR,ENDOLYSIN","4mif","PYRANOSE 2-OXIDASE","Phanerochaete chrysosporium",4,"ILE A 323;GLU A 305;HIS A 281;VAL A  42","None","1.00A","6j20A-4mifA:undetectable","6j20A-4mifA:21.83"]]